Tag: Antisense Therapeutics

Antisense Therapeutics: Starts dosing monkeys in ATL1102 toxicology study

FinTech Steve Sam - March 8, 2023

Antisense Therapeutics Starts dosing monkeys in ATL1102 toxicology studyAntisense Therapeutics (ANP) commences the dosing stage of a nine-month...

Antisense Therapeutics: Receives first approval for phase two DMD clinical trial

FinTech Steve Sam - February 14, 2023

Antisense Therapeutics Receives first approval for phase two DMD clinical trialAntisense Therapeutics (ANP) receives approval to conduct its...

Antisense Therapeutics: Shares rise on long COVID-19 study

FinTech Steve Sam - August 19, 2022

Antisense Therapeutics Shares rise on long COVID-19 studyAntisense Therapeutics (ANP) announces the outcomes of its collaboration to study...

Antisense Therapeutics: Raises $5.5M for Phase 2b clinical trial

Banking Steve Sam - January 4, 2020

Antisense Therapeutics: Raises $5.5M for Phase 2b clinical trialBiopharmaceutical company Antisense Therapeutics (ANP) has raised $5.5 million via...

Fintech News - Stay updated with the latest news in fintech, cryptocurrency, and financial technology.

Company

Headlines

First Abu Dhabi Bank Partners with Broadridge to Build Global Agency Securities Finance Business

0

Subheading First Abu Dhabi Bank collaborates with Broadridge Financial Solutions...

Proxymity and Citi Launch Vote Connect Global to Enhance Proxy Voting Efficiency

0

Subheading Proxymity collaborates with Citi Securities Services to launch Vote...

Mid-Tier Banks Invest Heavily in Payment Modernization with Volante Technologies

0

Subheading Volante Technologies' latest report reveals significant investments by mid-tier...

Axis Announces Proposed Redemption of Debentures Amid Strategic Asset Sale

0

Subheading Axis Auto Finance sets December 16, 2024, as the...

Newsletter

Get important news delivered directly to your inbox and stay connected!

© Newspaper WordPress Theme by TagDiv